微芯生物 (688321)

Shenzhen Chipscreen Biosciences Co., Ltd.

KSH

Tags

AI HealthcareDeepSeekSSE 580 IndexSSE Innovation IndexInnovative DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareContains Convertible BondsBuyback PlansForeign Capital BackgroundIntensive Research CoveragePlanned Reduction of HoldingsSTAR Market 200 IndexSTAR Market Biotechnology IndexHepatitis ConceptShareholder ReductionDispersed ShareholdingMargin Trading and Securities LendingHigh Price-to-Earnings Ratio医药生物

K-Line Chart

No K-line data available

Company NameShenzhen Chipscreen Biosciences Co., Ltd.
Listing Date2019-08-12
Issue Price20.43RMB
Registered Capital40779.647710k RMB
Legal RepresentativeLi Jianxun
Registered Address21F-24F, Building B, Zhigu Industrial Park, Shuguang Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province
IndustryChemical Pharmaceuticals
Main BusinessProviding patients with affordable and clinically urgently needed original new molecular entity drugs, possessing comprehensive capabilities from drug target discovery and validation, lead molecule discovery and evaluation to new drug clinical development, industrialization, academic promotion, and sales.
Company ProfileAs an innovative biopharmaceutical enterprise, the company consistently regards innovation and R&D as its core competitiveness. In 2016, 2017, and 2018, the company's R&D investment accounted for 60.52%, 62.01%, and 55.85% of its operating revenue, respectively. It has received support from numerous national, provincial, and municipal scientific research funds. As of the end of the reporting period, the company has cumulatively received 8 National Major Scientific and Technological Projects for "Major New Drug Creation," 7 National High-Tech Research and Development (863) Program projects, 1 National Innovation Fund for Technology-based SMEs, 1 Strategic Priority Research Program of the Chinese Academy of Sciences, 1 National Key R&D Program "Research on Reproductive Health and Prevention and Control of Major Birth Defects" key project, 5 Guangdong Provincial Science and Technology Plan projects, and 17 Shenzhen Municipal Science and Technology Plan funding awards.

Stock Details

1. Key Indicators

  • Total Shares(W): 40780.76
  • Circulating A-Shares(W): 40780.76
  • Earnings Per Share(RMB): 0.1735
  • Net Assets Per Share(RMB): 3.7571
  • Operating Revenue(W RMB): 67415.77
  • Total Profit(W RMB): 7031.48
  • **Net Profit Attributable to Parent(W RMB) **: 7076.75
  • Net Profit Growth Rate(%): 238.53
  • Weighted Return on Equity(%): 4.3700
  • Operating Cash Flow Per Share(RMB): 0.1470
  • Undistributed Profit Per Share(RMB): 0.1809
  • Capital Reserve Per Share(RMB): 2.4958

2. Main Business

The main business covers:

  • Pharmaceutical technology development and related commercialization
  • New drug research, development, technology transfer, and other related services
  • New therapeutic technology research, development, technology transfer, and other related services
  • Licensing of patents and technologies
  • Drug manufacturing
  • Production and operation of health foods

3. Company Basic Information

  • Company Name: Shenzhen Chipscreen Biosciences Co., Ltd.
  • Listing Date: Not Provided
  • Industry: Not Provided
  • Address: Not Provided
  • Website: Not Provided
  • Company Profile: Not Provided

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
Data Not Available Data Not Available Data Not Available Data Not Available Data Not Available

5. Concept Sectors

  • None

Remarks

  • Data update date: 2025-11-06
  • Data source: Public Market Information